Drugs

S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals

S6(R1) Preclinical Safety Evaluation of Biotechnology-Derived Pharmaceuticals

Note: In June 2011, the ICH incorporated the S6 Addendum with S6 and retitled the combined document S6(R1). The contents of S6 and the S6 Addendum reflect the contents of S6(R1).

Back to: International Conference on Harmonisation - Safety

Page Last Updated: 03/04/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.